Apollo Endosurgery

Apollo Endosurgery is a Texas-based medical device company that manufactures invasive suturing systems to treat gastrointestinal conditions. Read more

Charles McKhann's photo - CEO of Apollo Endosurgery

CEO

Charles McKhann

CEO Approval Rating

84/100

Founded:

2006

Status:

PublicIndependent CompanyNASDAQAPEN

APOLLO ENDOSURGERY TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

EGS is Apollo Endosurgery's biggest rival. EGS was founded in 2003, and is headquartered in Redmond, Washington. Like Apollo Endosurgery, EGS also works within the Health Care Equipment sector. EGS generates $30.2M less revenue vs. Apollo Endosurgery.

ReShape Lifesciences is one of Apollo Endosurgery's top competitors. ReShape Lifesciences's headquarters is in San Clemente, California, and was founded in 2002. Like Apollo Endosurgery, ReShape Lifesciences also works within the Health Care Equipment sector. ReShape Lifesciences generates 25% of Apollo Endosurgery's revenue.

OrphoMed is seen as one of Apollo Endosurgery's top competitors. OrphoMed is a Private company that was founded in 2015 in San Francisco, California. OrphoMed competes in the Health Care Services industry. Compared to Apollo Endosurgery, OrphoMed has 205 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is CapsoVision a competitor of Apollo Endosurgery?

Apollo Endosurgery Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$45.2M

Apollo Endosurgery's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 815.1M. Over the last four quarters, Apollo Endosurgery's revenue has grown by 145.5%. Specifically, in Q1 2021's revenue was $13.9M; in Q4 2020, it was $12.9M; in Q3 2020, it was $12.8M; in Q2 2020, Apollo Endosurgery's revenue was $5.6M.

Apollo Endosurgery Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Lpath

Sep 2016

Source »
undisclosed
Lpath is focused on the discovery and development of bioactive lipid-targeted therapeutic antibodies for treating and diagnosing human diseases.

These are all the companies that Apollo Endosurgery has acquired. Apollo Endosurgery's latest acquisition was Lpath in Sep 2016. Lpath is focused on the discovery and development of bioactive lipid-targeted therapeutic antibodies for treating and diagnosing human diseases.

Apollo Endosurgery Funding History

Since Apollo Endosurgery was founded in 2006, it has participated in 11 rounds of funding. In total Apollo Endosurgery has raised $312.1M. Apollo Endosurgery's last funding round was on Aug 2019 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Aug 2019
$20M
-
Post-IPO Equity
Jun 2018
$23.7M
-
Post-IPO Equity
Jul 2017
$31M
-
Equity
Dec 2016
$54.4M
-
Debt
Mar 2015
$50M

Since Apollo Endosurgery was founded in 2006, it has participated in 11 rounds of funding. In total Apollo Endosurgery has raised $312.1M. Apollo Endosurgery's last funding round was on Aug 2019 for a total of $20.0M

Apollo Endosurgery Investments

No recent investments found related to Apollo Endosurgery

These are all the companies that Apollo Endosurgery has invested in. Apollo Endosurgery's latest investment was Lpath in Sep 2016. Lpath is focused on the discovery and development of bioactive lipid-targeted therapeutic antibodies for treating and diagnosing human diseases.

Apollo Endosurgery News

May 12, 2021FinanzNachrichten

Apollo Endosurgery to Present at Sidoti Conference May 20

AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global ... See more »
May 4, 2021Zacks

Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 10.53% and 17.63%, respec... See more »
May 3, 2021MarketScreener

Announces Appointments to Commercial Leadership Team

(marketscreener.com) Apollo Endosurgery Announces Appointments to Commercial Leadership Team May 03, ... See more »
April 28, 2021BioSpace

Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021

Apollo Endosurgery, Inc. (NASDAQ:APEN), a global leader in next-generation minimally invasive medical... See more »
April 25, 2021Zacks

Will Apollo Endosurgery, Inc. (APEN) Report Negative Q1 Earnings? What You Should Know

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for ... See more »
April 21, 2021FinanzNachrichten

Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack Endoscopic HeliX Tacking System

Authors conclude, "Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closur... See more »

Apollo Endosurgery Press Releases

September 19, 2017Business Wire

Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less i... See more »
January 2, 2017Blackbird

United States, Canada And Brazil Intragastric Balloons Market Forecast 2017-2023 - Research and Markets

DUBLIN-(BUSINESS WIRE)-Research and Markets has announced the addition of the "US, Canada And Brazil ... See more »
October 17, 2016EIN Presswire

Automated Suturing Devices Market Application Analysis, Regional Outlook, Competitive Strategies & Forecast 2016 To 2027

Market research future published a Half-cooked research report on Global Automated Suturing Devices M... See more »
April 11, 2016Business Wire

Automated Suturing Devices Market - Key Players Are Medtronic, Apollo Endosurgery & Boston Scientific - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Automated Suturing D... See more »
February 1, 2016Business Wire

Global Surgical Devices Medical Pipeline Assessment 2015-2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xshpjp/surg... See more »
November 30, 2015PR Newswire

Global Specialty Surgical Endoscopy Products Market 2015 - The State of Development of Novel, Specialty Endoscopy Technologies

DUBLIN, November 30, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/res... See more »

Apollo Endosurgery Videos

February 12, 2020Apollo Youtube Channel

"The Apollo Mobile Learning Center" on YOUTUBE

April 3, 2017Apollo Endosurgery Youtube Channel

"OverStitch Endoscopic Suturing System" on YOUTUBE

February 10, 2017Apollo Endosurgery Youtube Channel

"Apollo Endosurgery Mobile Learning Center" on YOUTUBE

May 12, 2016Apollo Endosurgery Youtube Channel

"OverStitch Sleeve Revision" on YOUTUBE

May 12, 2016Apollo Endosurgery Youtube Channel

"OverStitch Outlet Revision" on YOUTUBE

May 12, 2016Apollo Endosurgery Youtube Channel

"OverStitch Full Animation SD" on YOUTUBE

September 26, 2014APOLLO ENDOSURGERY YOUTUBE CHANNEL

"LAP-BAND System Moments" on YOUTUBE

Social Media

Apollo Endosurgery Headquarters

1120 S. Capital of Texas Hwy Building 1, Suite 300

Austin, Texas78746

1-512-279-5100

Driving Directions »

Trending Companies

Apollo Endosurgery Summary

ABOUT

Overview

Apollo Endosurgery is a Texas-based medical device company that manufactures invasive suturing systems to treat gastrointestinal conditions. Apollo Endosurgery was founded in 2006. Apollo Endosurgery's headquarters is located in Austin, Texas, USA 787...

CEO

Apollo Endosurgery's CEO, Charles McKhann, currently has an approval rating of 84%. Apollo Endosurgery's primary competitors are EGS, ReShape Lifesciences & OrphoMed.

Frequently Asked Questions about Apollo Endosurgery

  1. When was Apollo Endosurgery founded?

    Apollo Endosurgery was founded in 2006
  2. Who is Apollo Endosurgery's CEO?

    Apollo Endosurgery's CEO is Charles McKhann
  3. How much revenue does Apollo Endosurgery generate?

    Apollo Endosurgery generates $45.2M in revenue
  4. How much funding does Apollo Endosurgery have?

    Apollo Endosurgery has historically raised $312.1M in funding
  1. Where is Apollo Endosurgery's headquarters?

    Apollo Endosurgery's headquarters is in Austin Texas, USA
  2. How many employees does Apollo Endosurgery have?

    Apollo Endosurgery has 215 employees
  3. What sector does Apollo Endosurgery operate in?

    Apollo Endosurgery is in Health Care Equipment
  4. Who are Apollo Endosurgery's competitors?

    Apollo Endosurgery's top competitors are EGS, ReShape Lifesciences, OrphoMed